372.25 USD
+7.75
2.13%
At close Mar 31, 4:00 PM EDT
Pre-market
372.01
-0.24
0.06%
1 day
2.13%
5 days
-0.93%
1 month
-3.61%
3 months
3.39%
6 months
3.04%
Year to date
3.77%
1 year
4.96%
5 years
123.59%
10 years
303.52%
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

187% more first-time investments, than exits

New positions opened: 255 | Existing positions closed: 89

18% more repeat investments, than reductions

Existing positions increased: 825 | Existing positions reduced: 701

6% more funds holding

Funds holding: 1,999 [Q3] → 2,122 (+123) [Q4]

2% less capital invested

Capital invested by funds: $110B [Q3] → $108B (-$1.66B) [Q4]

6% less call options, than puts

Call options by funds: $518M | Put options by funds: $550M

1.84% less ownership

Funds ownership: 79.99% [Q3] → 78.15% (-1.84%) [Q4]

4% less funds holding in top 10

Funds holding in top 10: 76 [Q3] → 73 (-3) [Q4]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$413
11%
upside
Avg. target
$437
17%
upside
High target
$450
21%
upside

10 analyst ratings

positive
80%
neutral
20%
negative
0%
Needham
Mike Matson
44% 1-year accuracy
54 / 124 met price target
19%upside
$442
Buy
Reiterated
21 Mar 2025
Citigroup
Joanne Wuensch
43% 1-year accuracy
22 / 51 met price target
21%upside
$450
Buy
Reinstated
26 Feb 2025
Barclays
Matt Miksic
63% 1-year accuracy
26 / 41 met price target
19%upside
$443
Overweight
Maintained
10 Feb 2025
Goldman Sachs
David Roman
30% 1-year accuracy
6 / 20 met price target
15%upside
$427
Neutral
Maintained
30 Jan 2025
Truist Securities
Richard Newitter
51% 1-year accuracy
22 / 43 met price target
11%upside
$413
Hold
Maintained
30 Jan 2025

Financial journalist opinion

Based on 12 articles about SYK published over the past 30 days

Negative
Investors Business Daily
4 days ago
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Tariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Neutral
GlobeNewsWire
5 days ago
Stryker announces intention to nominate Manny Maceda to board of directors
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company's board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.
Stryker announces intention to nominate Manny Maceda to board of directors
Neutral
GlobeNewsWire
6 days ago
Stryker announces Annual Meeting of Shareholders
Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows:
Stryker announces Annual Meeting of Shareholders
Positive
Zacks Investment Research
1 week ago
3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan
Tariffs are shaking up the Medical Device industry, but SYK, MDT & PODD are poised to thrive. Here's why three key players remain strong despite rising trade tensions.
3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan
Positive
Schwab Network
1 week ago
The Big 3: MMM, PM, SYK
Today's Big 3 focuses on what Dan Deming calls "defensive" plays in a market still exhibiting elevated volatility. He talks about why there's upside potential in 3M (MMM), Philip Morris (PM) and Stryker (SYK).
The Big 3: MMM, PM, SYK
Neutral
Zacks Investment Research
2 weeks ago
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls
SYK unveils next-gen Mako SmartRobotics, revolutionizing hip, knee and spine surgeries with greater precision and first-to-market robotic hip revision technology.
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls
Neutral
PRNewsWire
2 weeks ago
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Latest technology offers more applications and innovation across more specialties MAHWAH, N.J. , March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego.
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Neutral
PRNewsWire
3 weeks ago
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
PORTAGE, Mich. , March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
Positive
Zacks Investment Research
3 weeks ago
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio
Stryker launches Steri-Shield 8, a cutting-edge PPE system with enhanced fit, visibility and protection, reinforcing its leadership in medical safety.
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio
Positive
Zacks Investment Research
3 weeks ago
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Stryker's Sunc Badge is a Hands-free, wearable communication device that will support care team members with fast and reliable collaboration. It is likely to help offset the ongoing nurse shortage.
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Charts implemented using Lightweight Charts™